Efficacy and safety of standard and low dose ticagrelor versus clopidogrel in east AsianPatients with chronic total occlusion undergoing percutaneous coronary intervention: a single center retrospective study
Patients with coronary chronic total occlusion (CTO) require effective antiplatelet therapy after percutaneous coronary intervention (PCI). Ticagrelor has more pronounced platelet inhibition than clopidogrel. ...
Source: BMC Cardiovascular Disorders - Category: Cardiology Authors: Yong Wang, Hong-wei Zhao, Cheng-fu Wang, Xiao-jiao Zhang, Jie Tao, Chun-sheng Cui, Qing-kun Meng, Yu Zhu, De-feng Luo, Ai-jie Hou and Bo Luan Tags: Research article Source Type: research
More News: Angioplasty | Cardiology | Cardiovascular | Clopidogrel | Coronary Angioplasty | Heart | Men | Percutaneous Coronary Intervention | Plavix | Study